Literature DB >> 8572642

Proliferating cell nuclear antigen (PCNA) as a prognostic factor for colorectal cancer.

D Kovac1, M Rubinic, M Krasevic, S Krizanac, M Petrovecki, D Stimac, M Melato.   

Abstract

PCNA (proliferating cell nuclear antigen) is a cell cycle related protein that is maximally elevated in late G1 and S-phase of proliferating cells. 114 biopsy specimens of colorectal cancer were immunolabeled with PC 10 which specifically recognizes PCNA; Dukes' staging and histological grading were estimated for each case. All patients were followed-up for at least 60 months or to death. All data were analysed by the computer program NCSS (Number Cruncher Statistical System). According to the results, PCNA-index may be considered an independent prognostic factor for colorectal cancer; it may also be helpful in supporting the therapeutic strategies based only on Dukes' stage.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8572642

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

1.  Combination of three-gene immunohistochemical panel and magnetic resonance imaging-detected extramural vascular invasion to assess prognosis in non-advanced rectal cancer patients.

Authors:  Xiao-Fu Li; Zheng Jiang; Ying Gao; Chun-Xiang Li; Bao-Zhong Shen
Journal:  World J Gastroenterol       Date:  2016-10-14       Impact factor: 5.742

Review 2.  The USP7 protein interaction network and its roles in tumorigenesis.

Authors:  Ahood Al-Eidan; Yihua Wang; Paul Skipp; Rob M Ewing
Journal:  Genes Dis       Date:  2020-10-22
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.